Cite
MLA Citation
G. Cabibbo et al.. “OC.04.3 FIRST-LINE IMMUNE CHECKPOINT INHIBITOR-BASED SEQUENTIAL THERAPIES FOR ADVANCED HEPATOCELLULAR CARCINOMA: A RATIONALE FOR FUTURE TRIALS.” Digestive and liver disease, vol. 53, n.d., pp. S107–. http://access.bl.uk/ark:/81055/vdc_100144251782.0x000028